Filters
Hikma Ventures invests in Propeller Health for the enhancement of leading respiratory technology platform
Press Release, Corporate
Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”
Press Release, Corporate
Hikma Ventures invests in Chrono Therapeutics for the development of next generation trans-dermal drug delivery technolo...
Press Release, Corporate
Hikma delivers solid first half performance and reiterates full year revenue guidance of $2.0 billion to $2.1 billion
Press Release, Corporate
Regulatory approval of Hikma’s colchicine is upheld
Press Release, Corporate
Hikma announces launch of Generic Xeloda® Tablets 150 mg and 500 mg in the US
Press Release, Product
Hikma Pharmaceuticals to participate in the world economic forum's industry strategy meeting
Press Release, Responsibility
Hikma acquires six injectable products in Europe
Press Release, Corporate
Hikma receives FDA approval for Ketamine Hydrochloride Injection
Press Release, Product
Hikma announces FDA approval and launch of Fluticasone 50 MCG Spray, the store brand equivalent of Flonase
Press Release, Product
Michael Raya, CEO of West-Ward Pharmaceuticals, Hikma's wholly-owned subsidiary in the US, joins GPhA
Press Release, Corporate